Sarah Romano - Jan 5, 2022 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Chief Financial Officer
Signature
/s/ Sarah Romano
Stock symbol
KPRX
Transactions as of
Jan 5, 2022
Transactions value $
-$123
Form type
4
Date filed
1/6/2022, 04:10 PM
Previous filing
Dec 8, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability -$123 -114 -0.5% $1.08 22.9K Jan 5, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022.